Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Male hormones can decrease the ability of immune cells to fight bacteria.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

SARMs work differently in tissues due to unique interactions and structures.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Certain gene variations are significantly linked to hair loss, especially in white people.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Finasteride reduces melanin production in skin cells.

Androgenic alopecia is mainly caused by DHT, and new treatments focus on hair regeneration and aging factors.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Androgens can both increase and decrease hair growth in different parts of the body.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Antiandrogens help treat hormone-related conditions in both men and women.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.